United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-2146_b78b6da0-ce99-4c8f-bf36-c4e19b34dfd9
- Product NDC
- 0378-2146
- Form
- TABLET, FILM COATED
- Composition / generic term
- spironolactone
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19810203
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2146-01) · 0378-2146-01
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2146-05) · 0378-2146-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →